Julie H T Dang1, Moon S Chen2,3. 1. Community Engagement and Outreach, University of California, Davis Comprehensive Cancer Center, Sacramento, California. 2. Division of Hematology and Oncology, University of California, Davis School of Medicine, Sacramento, California. 3. Cancer Control/Cancer Health Disparities, University of California, Davis Comprehensive Cancer Center, Sacramento, California.
Abstract
BACKGROUND: Biospecimens from racially diverse groups are needed to advance cancer research. The Asian American Cancer Education Study was developed to increase the number and proportion of blood biospecimen donations from Asian Americans for cancer research. METHODS: The authors' targeted approach included 2 types of community engagement, in-reach (within institution to Asian American patients with cancer) and outreach (external to institution to the general Asian American community). Participants received in-language biospecimen education followed by the opportunity to donate blood biospecimens. Outreach participants donated through our community biospecimen blood drives, and in-reach participants consented to donating an extra tube of blood during their routine blood draws as a patient. Donated blood biospecimens were spun down to serum and plasma to be stored in a biorepository or were sent to the laboratory to test for cancer-related risk factors. RESULTS: Three hundred eighty-eight Asian Americans donated 1127 blood biospecimens for cancer research. Four hundred twenty tubes of plasma and serum are currently being stored at the cancer center's biorepository, 39 tubes have been used for cancer genomic research, and 668 tubes were used to characterize cancer-related risk factors. CONCLUSIONS: Building upon the past decade of the National Cancer Institute-funded Asian American Network for Cancer Awareness, Research, and Training's foundation of trust and service among Asian Americans, researchers were able to leverage relationships not only to introduce the idea of biospecimen contribution to the community but to also exceed expectations with regard to the quantity of blood biospecimens collected from Asian Americans. Cancer 2018;124:1614-21.
BACKGROUND: Biospecimens from racially diverse groups are needed to advance cancer research. The Asian American Cancer Education Study was developed to increase the number and proportion of blood biospecimen donations from Asian Americans for cancer research. METHODS: The authors' targeted approach included 2 types of community engagement, in-reach (within institution to Asian American patients with cancer) and outreach (external to institution to the general Asian American community). Participants received in-language biospecimen education followed by the opportunity to donate blood biospecimens. Outreach participants donated through our community biospecimen blood drives, and in-reach participants consented to donating an extra tube of blood during their routine blood draws as a patient. Donated blood biospecimens were spun down to serum and plasma to be stored in a biorepository or were sent to the laboratory to test for cancer-related risk factors. RESULTS: Three hundred eighty-eight Asian Americans donated 1127 blood biospecimens for cancer research. Four hundred twenty tubes of plasma and serum are currently being stored at the cancer center's biorepository, 39 tubes have been used for cancer genomic research, and 668 tubes were used to characterize cancer-related risk factors. CONCLUSIONS: Building upon the past decade of the National Cancer Institute-funded Asian American Network for Cancer Awareness, Research, and Training's foundation of trust and service among Asian Americans, researchers were able to leverage relationships not only to introduce the idea of biospecimen contribution to the community but to also exceed expectations with regard to the quantity of blood biospecimens collected from Asian Americans. Cancer 2018;124:1614-21.
Authors: Wanzhen Gao; Grace X Ma; Yin Tan; Carolyn Fang; Joellen Weaver; Ming Jin; Philip Lai; Andrew K Godwin Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-03 Impact factor: 4.254
Authors: Elisa K Tong; Lei-Chun Fung; Susan L Stewart; Debora A Paterniti; Julie H T Dang; Moon S Chen Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-03 Impact factor: 4.254
Authors: Clifford G Tepper; Julie H T Dang; Susan L Stewart; Dao M Fang; Kimberly A Wong; Stephenie Y Liu; Ryan R Davis; Doan Y Dao; Jeffrey P Gregg; Natalie J Török; Moon S Chen Journal: Cancer Date: 2018-04-01 Impact factor: 6.860
Authors: Elisa K Tong; Tung T Nguyen; Penny Lo; Susan L Stewart; Ginny L Gildengorin; Janice Y Tsoh; Angela M Jo; Marjorie L Kagawa-Singer; Angela U Sy; Charlene Cuaresma; Hy T Lam; Ching Wong; Mi T Tran; Moon S Chen Journal: Cancer Date: 2016-08-26 Impact factor: 6.860
Authors: Moon S Chen; Dao M Fang; Susan L Stewart; May Ying Ly; Serge Lee; Julie H T Dang; Tram T Nguyen; Annette E Maxwell; Christopher L Bowlus; Roshan Bastani; Tung T Nguyen Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04-23 Impact factor: 4.254
Authors: Helen M Moore; Carolyn C Compton; Mark D Lim; Jimmie Vaught; Katerina N Christiansen; Joe Alper Journal: Cancer Res Date: 2009-08-25 Impact factor: 12.701
Authors: Nadine J Barrett; Kearston L Ingraham; Kenisha Bethea; Pao Hwa-Lin; Maritza Chirinos; Laura J Fish; Schenita Randolph; Ping Zhang; Peter Le; Demetrius Harvey; Ronald L Godbee; Steven R Patierno Journal: Adv Cancer Res Date: 2020-03-19 Impact factor: 6.242
Authors: Nadine J Barrett; Elisa M Rodriguez; Ronaldo Iachan; Terry Hyslop; Kearston L Ingraham; Gem M Le; Kelly Martin; Rodney C Haring; Natalie A Rivadeneira; Deborah O Erwin; Laura J Fish; Deirdre Middleton; Robert A Hiatt; Steven R Patierno; Urmimala Sarkar; Elizabeth A Gage-Bouchard Journal: Cancer Date: 2020-01-07 Impact factor: 6.860
Authors: Hongxiang Gao; Baige Cao; Nan Dang; Song Gu; Min Xu; Bin Ji; Yiqi Shi; Shijian Liu; Congrong Wang Journal: Cancer Med Date: 2022-02-03 Impact factor: 4.452